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Nicotine-free, nontransgenic tobacco (*Nicotiana tabacum*[l]{.smallcaps}.) edited by CRISPR-Cas9\
Plant Biotechnology Journal\
<https://doi.org/10.1111/pbi.13193>**Value of the Data**•First nicotine-free, nontransgenic tobacco plant that enables the production of non-addictive cured tobacco.•Nicotine-free smoking products can support people to overcome nicotine addiction.•This technology can be transferred to commercially used *N. tabacum* varieties as well as *N. benthamiana* to improve the biotechnological production properties.•First technology that eliminates the nicotine content while all other metabolites are not affected.

1. Data {#sec1}
=======

The data shows the generation of a nicotine-free and nontransgenic tobacco plant by CRISPR-Cas9 mediated gene editing. After regeneration of plants and testing them for transgenity ([Fig. 1](#fig1){ref-type="fig"}) the nicotine content was analyzed by GC measurements in wild type, T~0~ and T~1~ generations ([Fig. 2](#fig2){ref-type="fig"}). Genomic analysis of T~1~ 3.1 plant revealed that not all *BBL* (berberine bridge enzyme-like) loci were knocked out (*BBLe*)([Fig. 3](#fig3){ref-type="fig"}). Therefore, further generations were grown and analyzed. The nicotine level of T~3~ 4.11.1.2 plant was reduced to 0.04 mg g^−1^ DW [@bib1] ([Fig. 4](#fig4){ref-type="fig"}). This was additionally confirmed by GC-MS measurements ([Fig. 5](#fig5){ref-type="fig"}). The genomic analysis showed knockout of all *BBL*-loci [@bib1]. The loss of the T-DNA cassette was proven for plant T~3~ 4.11.1.2 ([Fig. 6](#fig6){ref-type="fig"}). Finally, ^1^H NMR analysis showed no significant changes in primary metabolism ([Fig. 7](#fig7){ref-type="fig"}, [Fig. 8](#fig8){ref-type="fig"}, [Fig. 9](#fig9){ref-type="fig"}).Fig. 1Selection for positive transformants in T~1~-generation: Seeds from T~0~ -- plants were germinated on tissue paper and sprayed with a 100 mg L^−1^ PPT solution three times every two days. Seedlings of the wild type (left) died, seedlings from a transformed and regenerated plant (right) survived.Fig. 1Fig. 2Amount of nicotine in wild type, T~0~ and T~1~ plants: (A) the amount of nicotine was measured with GC-FID of 200 mg dried and grounded leaf material of plants extracted with MTBE. Amount of nicotine was calculated as mg per gram dry weight (DW). (B) amount of nicotine in extracts of T~1~ plants.Fig. 2Fig. 3Analysis of plant T~1~ 3.1 on genomic level: Fragments of all six *BBL* genes (*BBLa* -- *BBLe*) of the wild type (WT) and plant T~1~ 3.1 were amplified and cloned into a vector by Gibson Assembly for sequencing. Inserted bases are highlighted in red leading to a frame shift; PAM sequences are underlined and the gRNA sequence is shown in bold.Fig. 3Fig. 4GC chromatogram of crude extracts of *Nicotiana tabacum* leaves: comparison of crude extracts of tobacco leaves of the wild type and the nicotine-free plant (T~3~ 4.11.1.2). The red arrow marks the retention time of nicotine. (1.8 min - injection peak; 4.4 min - internal standard (quinoline); 5.5 min -- nicotine; 7.6 min -- anatabine).Fig. 4Fig. 5GC-MS analysis of plant extracts regarding the mass of nicotine: Extracts of the wild type (WT), plant T~1~ 3.1 and T~3~ 4.11.1.2 were analyzed with GC-MS measurements by the analysis of peaks corresponding to the *m*/*z* of nicotine (162.23 g/mol). Extracted Ion chromatogram (EIC) of the mass of nicotine and the corresponding mass spectra are shown.Fig. 5Fig. 6Test for non-transgenity of the nicotine-free plant: Leaf discs of the plants T~1~ 4.11 and T~3~ 4.11.1.2 were incubated in MS-medium with 6 mg L^−1^ PPT to test for the presence of the transformation cassette including the selection marker.Fig. 6Fig. 7^1^H-NMR spectrum of wild type leaf-extract in MeOD: 20 mg leaf material of wild type leaves were freeze-dried and extracted in MeOD. The region of aromatics (6 ppm--9 ppm) is highlighted in the zoom-in insert, showing signals corresponding to nicotine standard (see [Fig. 9](#fig9){ref-type="fig"}).Fig. 7Fig. 8^1^H-NMR spectrum of nicotine-free plant leaf-extract in MeOD: 20 mg leaf material of nicotine-free plant leaves were freeze-dried and extracted in MeOD. The region of aromatics (6 ppm--9 ppm) is highlighted in the zoom-in insert, indicating the absence of nicotine.Fig. 8Fig. 9^1^H-NMR spectrum of nicotine in MeOD.Fig. 9

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Plant material {#sec2.1}
-------------------

*Nicotiana tabacum* [l]{.smallcaps}. plants of the variety "Virginia Smoking Tobacco" (Strictly Medicinal Seeds LLC, United States) were cultivated on hydro culture at 25 °C under long day conditions (18 h light/6 h dark) with a light intensity of 110 μM m^−2^ s^−1^. For germination, seeds were surface sterilized with a sodium hypochlorite solution (1% active chlorine) and a few drops of Tween 20 for 10 minutes and washed three times with water before they were plated out on Murashige and Skoog Medium (4.4 g L^−1^ Murashige and Skoog Medium with Gamborg\'s Vitamins, 30 g L^−1^ sucrose, pH 5.8).

2.2. Plasmid construction {#sec2.2}
-------------------------

For the delivery of the CRISPR cassette to *N. tabacum* plants with *A. tumefaciens* a binary vector system was used [@bib2]. The chosen sgRNA target sequence (GAAATCAGAGTAAGGTGCGG) for the *BBL* genes was cloned into the vector pChimera according to the author\'s instructions and the resulting vector was named pChimera-BBL. The gRNA chimera was subsequently cloned into the vector pCas9-TPC according to the author\'s instructions resulting in the vector pCas9-BBL, which was used for transformation experiments. All cloned vectors were verified by sequencing.

For the verification of the targeted mutagenesis on genomic level, gene sequences of the six *BBL* genes that include the target site were amplified with specific primers for each gene from genomic DNA of wildtype and transgenic plants. For sequencing, the gene fragments were either cloned into the vector pDionysos [@bib3] by using the Gibson Assembly method or the PCR product was directly sequenced. Used primers are listed in [Table 1](#tbl1){ref-type="table"}.Table 1Primers used in the study.Table 1Primer NameSequence (5′ → 3′)purposeBBL_gRNA_fwd[ATTG]{.ul}GAAATCAGAGTAAGGTGCGGsgRNA targetBBL_gRNA_rev[AAAC]{.ul}CCGCACCTTACTCTGATTTCsgRNA targetSS129CACAGGAAACAGCTATGACColony PCR pChimera-BBLSS42TCCCAGGATTAGAATGATTAGGColony PCR; Sequencing pChimera-BBLSS43CGACTAAGGGTTTCTTATATGCColony PCR;SS61GAGCTCCAGGCCTCCCAGCTTTCGSequencing pCas9-BBLBBLa_Gib_fwdTCACACTGGCGGCCGCTCGAGCATGCATACTGCTACTGGAGCTGTTACGibson Assembly pDionysosBBLa_Gib_revATAACTAATTACATGATGCGGCCCTTGCAGGTCTCAGCAGTACTCGibson Assembly pDionysosBBLb_Gib_fwdTCACACTGGCGGCCGCTCGAGCATGCATCTCTGCTACTGCAACTAGTGGAGibson Assembly pDionysosBBLb_Gib_revATAACTAATTACATGATGCGGCCCTATTTCCTCCTCCGCCACCTCGibson Assembly pDionysosBBLc_Gib_fwdTCACACTGGCGGCCGCTCGAGCATGCATTGGAGCAGGAGAAGGAGTGibson Assembly pDionysosBBLc_Gib_revATAACTAATTACATGATGCGGCCCTGGGCAACGTATTGTTTGGAGibson Assembly pDionysosBBLd1_Gib_fwdTCACACTGGCGGCCGCTCGAGCATGCATTTCGGTCTCTGCAACAACGibson Assembly pDionysosBBLd1_Gib_revATAACTAATTACATGATGCGGCCCTGAAACTGGTCACGGTCTTGibson Assembly pDionysosBBLd2_Gib_fwdTCACACTGGCGGCCGCTCGAGCATGCATCTCTTCAGCGTTTGCTCATAGibson Assembly pDionysos, amplificationBBLd2_Gib_revATAACTAATTACATGATGCGGCCCTCAAATCTACCGAAACATCATCTGibson Assembly pDionysosBBLe_Gib_fwdTCACACTGGCGGCCGCTCGAGCATGCATGGAGCAGGAGGAGTTACAAATCGibson Assembly pDionysosBBLe_Gib_revATAACTAATTACATGATGCGGCCCTTGGCGTCATCATTCTTAGCGGibson Assembly pDionysospDio_seq_fwdCGGTTTGTATTACTTCTTATTCColony PCRpDio_seq_revGATGTGGGGGGAGGGCGTGAATGTAColony PCR; sequencingPCR_BBLa_fwdACTGCTACTGGAGCTGTTACamplification *BBLa*BBLa_revTGCAGGTCTCAGCAGTACTCamplification *BBLa*BBLa_seq_fwdGCACCTTTCATGCCGAAACCsequencing *BBLa*PCR_BBLb_fwdTGGAGCAGGAGGTGGAGTTGamplification *BBLb*BBLb_revATTTCCTCCTCCGCCACCTCamplification *BBLb*BBLb_seq_fwdGCATCTTACATGCCGAAACCsequencing *BBLb*PCR_BBLc_fwdTGGAGCAGGAGAAGGAGTTGamplification *BBLc*BBLc_revGGGCAACGTATTGTTTGGAGamplification *BBLc*BBLc_seq_fwdGCATCTAACATGCCGAAACCsequencing *BBLc*PCR_BBLd1_fwdTTCGGTCTCTGCAACAACTCamplification *BBLd1*BBLd1_revGAAACTGGTCACGGTCTTGGamplification *BBLd1*BBLd1_seqATTCGCAGCGTGCTCTAAACsequencing *BBLd2*BBLd2_seqCCGTCTCTGCTACAAATCTCsequencing *BBLd2*

2.3. Plant transformation and regeneration {#sec2.3}
------------------------------------------

*A. tumefaciens GV3101::pMP90* cells were transformed with the plasmid pCas9-BBL as described previously [@bib4]. Transformation of *N. tabacum* leaves and the followed plant regeneration were done according to an existing protocol with minor changes [@bib5]. Plants were infiltrated with an OD~600\ nm~ of 0.1 and incubated for 3 days at long day conditions. For plant regeneration infiltrated leaves were surface sterilized, cut into pieces and incubated on shooting medium (2.15 g L^−1^ Murashige and Skoog Medium with Gamborg\'s Vitamins, 30 g L^−1^ sucrose, 0.1 mg L^−1^ indole-3-butyric acid, 0.8 mg L^−1^ benzylaminopurine, 250 mg L^−1^ carbenicillin, 6 mg L^−1^ DL-phosphinothricin (PPT), 8 g L^−1^ agar, pH 5.2) under long day conditions. Developed shoots were transferred to rooting medium (2.15 g L^−1^ Murashige and Skoog Medium with Gamborg\'s Vitamins, 30 g L^−1^ Sucrose, 0.5 mg L^−1^ indole-3-butyric acid, 250 mg L^−1^ carbenicillin, 6 mg L^−1^ DL-phosphinothricin (PPT), 8 g L^−1^ agar, pH 5.2) for approximately 10 days.

2.4. Test for transgenic plants {#sec2.4}
-------------------------------

Seeds from regenerated plants were collected and seeded out for growing the T~1~ generation. To test if these plants were transgenic, 7 days-old plantlets were sprayed with a solution of 100 mg L^−1^ PPT three times every two days. Survived plants were considered as transgenic and grown for further experiments.

Plants in T~2~ generation can be tested for the loss of the CRISPR-Cas9 cassette. For this purpose leaves of T~2~ generation plants were surface sterilized for 10 minutes with sodium hypochlorite (0.5% active chlorine) and a few drops of Tween 20 followed by three washing steps with water. Leaf discs were cut out with a cork borer and incubated on selection medium (4.4 g L^−1^ Murashige and Skoog Medium with Gamborg\'s Vitamins, 30 g L^−1^ sucrose, 6 mg L^−1^ PPT; pH 5.8) under standard growing conditions. Additionally, validation of the loss of the CRISPR cassette was done with PCR. Genomic DNA of the plants was isolated and amplification of the CRISPR cassette was done by the use of primers SS43 and SS61.

2.5. Plant extracts {#sec2.5}
-------------------

For the extraction of alkaloids a modified version of the extraction protocol from Lewis et al. [@bib6] was used. For the extraction 50 mg or 100 mg of ground leaves with 1 mL of a 2 N NaOH to moisten the sample in a glass vessel with a screw-cap. After 15 minutes of incubation time 5 mL of methyl tert-butyl ether (MTBE) containing 0.4 mg ml^−1^ quinoline used as an internal standard were added to the sample. Samples were incubated for 2.5 h with shaking at 200 rpm. For layer separation the glass vessels were stored without shaking overnight. The MTBE layer was used for gas chromatographic analysis.

2.6. Gas chromatographic analysis {#sec2.6}
---------------------------------

Measurements of plant extracts were done with an Agilent Technologies 7890A GC system equipped with a flame ionization detector (FID) set to 300 °C and a VF-5ms column (CP8944; 30 m × 0.25 mm, ID 0.25 μm). H~2~ flow was set to 30 mL min^−1^, Air Flow to 400 ml min^−1^ and N~2~ flow to 30 mL min^−1^. Injector temperature was set to 250 °C and 1 μL of the sample was injected in splitless mode. Initial oven temperature was set to 110 °C, held for 1 minute and increased afterwards to 200 °C with a rate of 10 °C/min followed by an increase to 300 °C in steps of 25 °C/min. The temperature of 300 °C was held for 10 minutes.

For GC-MS measurements a Thermo Scientific Trace GC Ultra system with a ISQ mass spectrometer and a TG-SQC column (Thermo Scientific; 15 m × 0,25 mm, ID 0,25 μm) was used. Injector temperature was set to 90 °C and 1 μL of the sample was injected in splitless mode. Initial oven temperature was set to 60 °C for 1 min, followed by an increase of the temperature to 200 °C with a rate of 10 °C/min. Afterwards the temperature was increased to 300 °C with a rate of 25 °C/min which was held for 10 minutes. Helium was used as a carrier gas with a flow of 0.7 ml min^−1^.

2.7. ^1^H-NMR analysis {#sec2.7}
----------------------

For NMR analysis, 20 mg of freeze-dried leaf material of the wild type and the nicotine-free plant or 10 mg of nicotine standard were mixed with 1 mL methanol-D4 and vortexed for one minute. After ultrasonication for 15 minutes the samples were centrifuged at 13,000 g for 5 minutes. Around 600 μL of the supernatant was filled into a 3 mm NMR-tube. ^1^H**-**NMR measurements were done at 25 °C and 600 MHz with the Bruker AV 600 Avance III HD (Cryoprobe) spectrometer. The data were analyzed using TopSpin 4.0.
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